Sort
21,281 grants matching “influenza”
Development of antivirals for newly emerging pathogens Ebola and Marburg.
$227,010Matteo Porotto · Weill Medical Coll Of Cornell Univ · R21 · FY2013 · AI
Novel Preventive HIV Vaccines
$227,000Baozhong Wang · Georgia State University · R21 · FY2016 · AI
LAIV Inducing Cross Protection
$227,000Sang-Moo Kang · Georgia State University · R21 · FY2016 · AI
Measuring Influenza and H1N1 vaccine responses in immunodeficient patients
$226,954Paul Joseph Utz · Stanford University · U19 · FY2011 · AI
Pathogenesis, Treatment and Prevention of Emerging Infectious Diseases
$226,923H. Clifford Lane · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
Pharmacy-centered Rapid ARV Network: Capacity-building for status-neutral ART/PrEP services within Southern community pharmacies
$226,902Aadia Rana · University Of Alabama At Birmingham · R21 · FY2025 · AI
The role of MMP activity in T cells during influenza virus pathogenesis
$226,845Bas Baaten · Sanford Burnham Prebys Medical Discovery Institute · R21 · FY2009 · AI
Impaired NK cell function by the synthetic food additive tBHQ
$226,811Cheryl Elizabeth Rockwell · Michigan State University · R21 · FY2023 · ES
Forecasting influenza epidemics using a mechanistic epidemic model
$226,676Rita Mangione-Smith · Kaiser Foundation Research Institute · R01 · FY2020 · AI
Maintenance of Immunologic Memory to Measles Vaccine
$226,670University Of California Davis · R01 · FY2001 · AI
Immunoassay and Imaging Core
$226,642Stuart P Weisberg · Columbia University Health Sciences · U19 · FY2023 · AI
Intestinal NOD2 and the microbiota enhance Coxsackievirus B3 pathogenesis
$226,641Arina Marijke Keestra-Gounder · University Of Colorado Denver · R21 · FY2025 · AI
Memory CD8 T cell subset cooperation via chemokines in protective immunity to inf
$226,636E. John Wherry · Wistar Institute · R21 · FY2007 · AI
Lambda phage as a scaffold for influenza immunization
$226,611Stephen Dewhurst · University Of Rochester · R21 · FY2008 · AI
Blocking TMPRSS2 expression for prevention of SARS-CoV-2 infection
$226,500Houjian Cai · University Of Georgia · R21 · FY2021 · AI
Oxidative killing of Pneumococcus
$226,500Balazs Rada · University Of Georgia · R21 · FY2021 · AI
Novel vaccine to CMV based on a disc virus
$226,500Alistair McGregor · University Of Minnesota · R21 · FY2010 · AI
MOLECULAR MECHANISMS OF VIRAL MEMBRANE FUSION
$226,465University Of Virginia Charlottesville · R01 · FY2001 · AI
Prospective Studies of Avian Influenza Transmission in Asia
$226,433Gregory Charles Gray · University Of Iowa · R01 · FY2009 · AI
Real-time detection and identification of single viruses
$226,304Lukas Novotny · University Of Rochester · R21 · FY2010 · AI
NON-CANONICAL MECHANISMS FOR INTERFERON-LAMBDA REGULATION OF SARS-COV-2 INFECTION
$226,254Emily Ann Hemann · Ohio State University · R21 · FY2023 · AI
Beneficial effects of quercetin in COPD - a preliminary clinical trial
$226,253Umadevi Sivanappa Sajjan · University Of Michigan At Ann Arbor · R21 · FY2013 · AT
Regulation of mucosal immunity to respiratory viruses by Tpl2
$226,250Wendy T Watford · University Of Georgia · R21 · FY2019 · AI
T cell responses to H1N1 and a longitudinal study of seasonal flu vaccination
$226,190Mark M Davis · Stanford University · U19 · FY2011 · AI
Mimicking evolution to define mechanisms of airborne transmission of H7N9 viruses
$226,169Troy Clavell Sutton · Pennsylvania State University, The · R21 · FY2021 · AI